German chemicals giant Bayer will invest about US$8 billion in the United States in agriculture research in conjunction with Monsanto, which it is purchasing, the companies said on Tuesday.
The announcement came after a “very productive meeting” last week between President-elect Donald Trump, Bayer CEO Werner Baumann and Monsanto chief Hugh Grant.
The joint statement did not however confirm the announcement by a Trump spokesman that Bayer will create “at least 3,000 new US high-tech jobs,” and retain “100 per cent of Monsanto’s 9,000 plus US workforce.”
“The combined company expects to spend approximately US$16 billion for R&D in agriculture over the next six years with at least half of this investment made in the United States,” the Bayer-Monsanto statement said.
“This is an investment in innovation and people that will create several thousand new high-tech, well-paying jobs after integration is complete.”
It was the third announcement of US investment and job creation plans by a major company on Tuesday, just three days before Trump’s inauguration. Trump quickly took credit in a pair of tweets that came shortly after announcements from General Motors and Walmart.
“With all of the jobs I am bringing back into the US (even before taking office), with all of the new auto plants coming back into our country and with the massive cost reductions I have negotiated on military purchases and more, I believe the people are seeing ‘big stuff.’”
Monsanto shareholders last month approved the US$66 billion takeover of the US company by Bayer. The deal is expected to close by the end of 2017 pending approval by antitrust officials in the US and Europe.
Bayer-Monsanto, which will be headquartered in St. Louis, said its US investment will be in “global seeds and traits research and development.”
Full Content: Channel News Asia
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Massachusetts AG Sues Insulin Makers and PBMs Over Alleged Price-Fixing Scheme
Jan 14, 2025 by
CPI
Apple and Amazon Avoid Mass Lawsuit in UK Over Alleged Collusion
Jan 14, 2025 by
CPI
Top Agent Network Drops Antitrust Suit Against National Association of Realtors
Jan 14, 2025 by
CPI
Weil, Gotshal & Manges Strengthens Antitrust Practice with New Partner
Jan 14, 2025 by
CPI
Russian Court Imposes Hefty Fine on Google for Non-Compliance with Content Removal Orders
Jan 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand